http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ebee37153f9885a4a20b19c8bb0a41b
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Berg |
| name | Daniela Berg |
| given-name | Daniela |
| organization-name | Department of Neurodegeneration; Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases; Tuebingen Germany Center of Neurology Department of Neurodegeneration and Hertie Institute of Clinical Brain Research University of Tübingen Tübingen Germany Department of Neurology, University Hospital Tuebingen, Site Investigator University of Tuebingen Tuebingen Germany Center of Neurology, Department of Neurodegeneration and Hertie‐Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany; Department of Neurology Christian‐Albrechts‐University Kiel Germany Department of Neurology Christian Albrecht University Kiel Germany; Hertie Institute for Clinical Brain Research Tübingen Tübingen Germany Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research and Center of Neurology University of Tübingen Tübingen Germany; Department of Neurology University Hospital Schleswig‐Holstein, Kiel University Kiel Germany Division of Molecular Genome Analysis German Cancer Research Center (DKFZ) Heidelberg Germany Department of Neurology, University Hospital Kiel , 24105 Kiel , Germany German Center of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research, Tübingen, Germany; Department of Neurology, Christian Albrecht University, Kiel, Germany Department of Pharmacology, The B. Rappaport Institute of Medical Research, Technion–Israel Institute of Technology, Haifa 31096, Israel; Department of Medical Genetics and Institute of Brain Research, University of Tübingen, Tübingen D-72076, Germany; and Division of Neurobiology, Departments of Psychiatry, Neurology, and Neuroscience, Johns Hopkins University, Baltimore, MD 21205 Department of Neurology Christian‐Albrechts University Kiel Germany Hertie Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, Tübingen, Germany; Department of Neurology, Christian-Albrechts-University, Kiel, Germany Department of Neurology, University Medical Center Schleswig-Holstein, Kiel, Germany Department of Neurology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany Neurologische UNI‐Klinik Universitätsklinikum Tübingen Tübingen Germany From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B.,... Department of Neurodegeneration and Hertie‐Institute for Clinical Brain Research University of Tübingen Tübingen Germany; Department of Neurology Christian‐Albrechts‐University Kiel Kiel Germany Department for Neurodegenerative Diseases, Hertie–Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany; Department of Neurology Christian‐Albrechts‐University of Kiel Kiel Germany Department of Neurodegenerative Diseases Hertie Institute for Clinical Brain Research University of Tübingen Germany; Department of Neurology Christian‐Albrechts‐University Kiel Germany Department of Neurology Christian‐Albrechts University of Kiel Kiel Germany; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany Department of Neurology Christian‐Albrechts‐University of Kiel Kiel Germany University of Tübingen, Germany Center of Neurology, Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases, Hoppe-Seyler-Strasse 3, 72076 Tübingen, Germany. daniela.berg@uni-tuebingen.de Department of Neurology; Montreal General Hospital; Montreal Quebec Canada Department of Neurology, Christian-Albrecht-University, Kiel, Germany;; Department of Neurodegeneration, University of Tübingen, Tübingen, Germany Hertie‐Institut für klinische Hirnforschung Tubingen Germany; Department of Neurology Christian‐Albrechts‐University Kiel Germany Department of Neurology, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany; German Center for Neurodegenerative Diseases Tübingen Germany; Department of Neurology Christian‐Albrechts‐University Kiel Germany From the Klinik für Neurologie (C.J., F.L., K.S., D.B., E.S.); Institut für Klinische Chemie (J.D., F.L.), Universitätsklinikum Schleswig-Holstein, Kiel/Lübeck; and Robert Koch Institut (S.B., S.D.), Nationales Referenzzentrum für Poliomyelitis und Enteroviren, Berlin, Deutschland. Department of Neurology, Christian-Albrechts-University, Kiel, Germany Department of Neurology, University Hospital Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany Department of Neurology University Hospital Schleswig‐Holstein, Campus Kiel and Christian Albrechts‐University of Kiel Kiel Germany From the Department of Neurodegeneration (D.B.), Hertie-Institute of Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tübingen, Germany; and Sheffield Institute for Translational Neuroscience (SITraN) (O.B.), University of Sheffield, Sheffield, UK. Department of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany Department of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany. Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Tuebingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany. From the Department of Neurology and Hertie-Institute for Clinical Brain Research (L.S., R.S., D.B.) and Department of Neuroradiology (T.N.), Eberhard-Karls-University, Tübingen, Germany. Department of Neurodegeneration Hertie‐Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases Tuebingen Germany Hertie Institute for Clinical Brain Research, Department of Neurodegeneration Center of Neurology, University of Tuebingen Tuebingen Germany; DZNE German Center for Neurodegenerative Diseases Tuebingen Tuebingen Germany Authors' Affiliations: 1Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia; 2Institute of Pathology and 3Institute of Obstetrics and Gynecology, Technische Universität München, Munich, Germany; 4University of California at San Francisco, San Francisco, California; 5Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania; 6Institute of Pathology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany; 7Institute of Pathology and 8Institute of Gynecology, Rosenheim Clinic, Rosenheim, Germany Department of Neurology Christian‐Albrechts‐Universität Kiel Germany Department of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research Tuebingen, Germany Center of Neurology Department of Neurodegeneration and Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany; DZNE German Center for Neurodegenerative Diseases Tübingen Germany Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Tübingen, Germany; Department of Neurology, Christian-Albrechts-University Kiel, Kiel, Germany. Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany; German Center for Neurodegenerative Diseases (DZNE) Bonn Germany Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany Department of Neurology, Christian-Albrechts-University, Kiel, Germany; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany Department of Neurology, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany From the Hertie Institute for Clinical Brain Research (S.B., M.B., K.B., T.G., K.M., S.S., C.S., M.Z., D.B., I.L.-S.), Department of Neurodegenerative Diseases, University of Tübingen, Germany; Department of Psychology (S.B.), University of Calgary, AB, Canada; German Center for Neurodegenerative Diseases (DZNE) (M.B., K.B., T.G., K.M., S.S., C.S., M.Z., I.L.-S.), University of Tübingen; Diagnostics and Cognitive Neuropsychology (H.-C.N.), Department of Psychology, Eberhard Karls University Tübingen... Department of Neurology, Christian-Albrechts-University Kiel, Kiel, Germany German Center for Neurodegenerative Diseases (DZNE) Bonn Germany; Department of Neurodegeneration Hertie Institute for Clinical Brain Research Tübingen Germany Department of Neurology, Kiel University, Kiel, Germany Department of Neurology University Hospital Schleswig‐Holstein Campus Kiel and Kiel University Kiel Germany Department of Neurodegeneration and Hertie‐Institute of Clinical Brain Research of the Eberhard‐Karls‐University German Center for Neurodegenerative Diseases Tübingen Germany Department of Neurodegeneration Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases Tuebingen Germany Department of Neurology; Christian-Albrechts-University; Kiel Germany; Department of Neurodegeneration; Hertie Institute for Clinical Brain Research, University of Tuebingen; Tuebingen Germany Center of Neurology Department of Neurodegeneration and Hertie Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany; German Center for Neurodegenerative Diseases University of Tuebingen Tuebingen Germany Department of Neurology Christian‐Albrechts‐University of Kiel and Hertie‐Institute for Clinical Brain Research, University of Tuebingen Tuebingen Germany Department of Neurology University Medical Center Schleswig‐Holstein, Campus Kiel, Kiel University (CAU) Kiel Germany; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany Center of Neurology, Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany; German Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany German Center of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research Tübingen Germany; Department of Neurology Christian Albrecht University Kiel Germany Department of Neurodegeneration, Hertie Institute of Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Centre for Neurodegenerative Diseases, Tübingen, Germany From the Department of Neurology (E.S., K.N., V.H., D.B.) and Institute of Experimental Medicine, Medical Ethics (A.R.), Christian-Albrechts-University of Kiel; Neurological Centre (C.L., B.H.), Hospital for Movement Disorders and Parkinson's Disease, Bad Segeberg; Department of Performance, Neuroscience, Therapy and Health (B.H.), MSH–Medical School Hamburg; Department of Neurodegeneration (D.B.), Hertie Institute for Clinical Brain Research, University of Tübingen, Germany. Christian-Albrechts-University of Kiel, Kiel, Germany. Institut für Pathologie, Technische Universität München, Munich, Germany. German Center for Neurodegenerative Diseases (DZNE) Tuebingen Germany; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH) University of Tuebingen Tuebingen Germany From the Department of Neurology (Dr. Becker), Saarland University/Homburg, Department of Neurology (Drs. Berg and Naumann), University of Würzburg, Germany; and Human Genetics (Dr. Francis), Welcome Trust Center for Human Genetics, Oxford, UK. Department of Neurology Christian‐Albrechts‐University Kiel Germany; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany Department of Neurology Christian‐Albrechts‐University of Kiel Kiel Germany; Department of Neurodegeneration Hertie Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany; German Center for Neurodegenerative Diseases (DZNE) Tübingen Germany Department of Neurology Christian‐Albrechts‐University of Kiel and Hertie‐Institute of Clinical Brain Research, University of Tübingen Germany Hertie‐Institute for Clinical Brain Research Tübingen Germany; Department of Neurodegeneration University of Tübingen and German Centre for Neurodegenerative Diseases (DZNE) Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Hoppe-Seyler Str. 3, 72076 Tuebingen, Germany; German Center of Neurodegenerative Diseases (DZNE), 72076 Tuebingen, Germany From the Department of Neurology (D.B.), Christian-Albrechts-University, Kiel, Germany; Molecular Neurobiology Laboratory (G.F.C., M.A.S.), Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown; Harvard Medical School (G.F.C., M.A.S.), Boston, MA; Parkinson's Foundation Research Advocates Program (J.L.K.), Parkinson's Foundation, Miami, FL/New York, NY; Northwestern University Feinberg School of Medicine (T.S.), Weill Institute for... Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, 72076 Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, 72076 Tuebingen, Germany. Department of Neurology University Hospital Schleswig‐Holstein, Campus Kiel Kiel Germany Hertie Institute for Clinical Brain Research, University of Tübingen Center of Neurology, Hoppe-Seyler-Straße 3, 72076 Tübingen, Germany Neurology Center, Hertie Institute for Clinical Brain Research, Department of Neurodegenerative Diseases University of Tübingen Tübingen Germany Department of Neurodegeneration, Center for Neurology and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tuebingen, Germany; Department of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany Hertie Institute for Clinical Brain Research Department of Neurodegenerative Diseases Tübingen Germany; Department of Neurology Christian‐Albrechts‐University of Kiel Kiel Germany Hertie‐Institut für klinische Hirnforschung Tubingen Germany DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany; Department of Neurodegeneration, Center of Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Germany Department of Medical GeneticsUniversity of Tuebingen Tuebingen Germany; Center of NeurologyHertie Institute for Clinical Brain ResearchUniversity of Tuebingen Tuebingen Germany Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Research Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany; Department of Neurology, Kiel University, Kiel, Germany From the Department of Neurology, Bayerische Julius-Maximilians-Universität Würzburg, Germany. Department of Neurology University Medical Center Schleswig‐Holstein Kiel Germany; Center for Neurology and Hertie Institute for Clinical Brain Research, Department of Neurodegenerative Diseases University Hospital Tübingen, and Center for Neurodegenerative Diseases Tübingen Germany Department of Neurology, UKSH, Campus Kiel Christian‐Albrechts‐University Kiel Germany Department of Neurology Christian‐Albrechts‐University Kiel Germany; Hertie Institute for Clinical Brain Research (HIH), Department of Neurodegeneration University of Tübingen Tübingen Germany Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany Department of Neurology Christian‐Albrechts‐University of Kiel Kiel Germany; Department of Neurodegeneration Hertie Institute for Clinical Brain Research, University of Tübingen Tübingen Germany Department of Neurodegeneration Hertie Institute for Clinical Brain Research (HIH) University of Tübingen Tübingen Germany; German Center for Neurodegenerative Diseases (DZNE) Tübingen Germany; Department of Neurology University Medical Center Schleswig‐Holstein Kiel Germany Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel, Germany; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tübingen, Germany; Department of Neurology, Christian-Albrechts-University, Kiel, Germany Department of Neurology Christian‐Albrechts‐University of Kiel Kiel Germany; Department of Neurodegeneration Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany German Parkinson Study Group; Marburg Germany; Department of Neurodegeneration; Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases; Tübingen Germany Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany Department of Neurology Christian‐Albrechts‐University of Kiel Kiel Germany; Department of Neurodegenerative Diseases Hertie Institute for Clinical Brain Research, University of Tübingen Tübingen Germany Center for Neurology and Hertie Institute for Clinical Brain Research, Department of Neurodegenerative Diseases University Hospital Tübingen, and Center for Neurodegenerative Diseases Tübingen Germany; Department of Neurology University Medical Center Schleswig‐Holstein Kiel Germany Department of Neurodegeneration, Hertie Institute of Clinical Brain Research University of Tübingen Tübingen Germany; German Center for Neurodegenerative Diseases, Department of Neurodegeneration Tübingen Germany; Department of Neurology University‐Hospital‐Schleswig‐Holstein, Christian‐Albrechts‐University Kiel Germany Department of Neurology Christian‐Albrechts‐University Kiel Germany From the Department of Neurology (T.R., J.S.B., K.H.S., G.D., D.B., R.B., F.L.), Department of Rheumatology (R.Z.), and Neuroimmunology, Institute of Clinical Chemistry (F.L.), Division of Neurological Pain Research and Therapy (R.B.), University Hospital of Schleswig-Holstein, Kiel, Germany; Department of Neurology (T.R.), University of Florida, Gainesville, FL; and Institute of Neuropathology (I.M., W.B.), University Hospital Göttingen, Germany. From the Center of Neurology, Department of Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research (K.B., S.L., S.S.D., J.G.S., A.A., A.-K.H., I.L.-S., D.B., T.G., C.S., W.M.), and German Center for Neurodegenerative Diseases (DZNE) (K.B., S.L., A.A., A.-K.H., I.L.-S., T.G., C.S.), University of Tübingen; and Department of Neurology (D.B., W.M.), Christian-Albrechts University, Kiel, Germany. German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany; Department of Neurology, Christian Albrecht University, Kiel, Germany Department of Neurology, Christian-Albrechts-University of Kiel, Tuebingen, Germany Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen and German Center for Neurodegenerative Diseases, Tuebingen, Germany; Department of Neurology, Christian-Albrechts-University Kiel, Kiel, Germany Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany; Department of Neurology, German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany; Department of Neurology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany Department of Neurology, Christian-Albrecht-University Kiel, Kiel, Germany; German Centre of Neurodegenerative Diseases (DZNE), Tübingen, Germany Department of Neurology Christian‐Albrechts‐University Kiel Kiel Germany Department of Neurology Christian‐Albrechts‐University of Kiel, Kiel, Germany and Hertie‐Institute of Clinical Brain Research, Department of Neurodegeneration Tübingen Germany Department of Neurology Christian‐Albrechts‐University of Kiel Kiel Germany; Department of Neurodegeneration Hertie‐Institute for Clinical Brain Research Tübingen Germany From the Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research (K.B., K.S., A.-K.H., C.S., C.D.M., T.G., D.B.), University of Tübingen, Tübingen; German Center for Neurodegenerative Diseases (DZNE) (K.B., K.S., A.-K.H., C.S., T.G., D.B.), Bonn; Department of Neurology (R.H., S.B.) and Institut of Neuroradiology (U.P., J.M., E.H.), JW Goethe University, Frankfurt/Main; and Gertrudis Klinik (I.C.), Parkinson-Center, Leun-Biskirchen, Germany. Department of Neurology Christian‐Albrechts University Kiel Germany; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Germany Department of Neurodegeneration, Hertie Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany; Department of Neurology Christian‐Albrechts‐University Kiel Germany Center of Neurology, Department of Neurodegeneration and Hertie‐Institute for Clinical Brain Research University of Tübingen Tübingen Germany; Department of Neurology Christian‐Albrechts University Kiel Germany Department of Neurology, Memory Disorders and Plasticity Group, University Hospital Schleswig-Holstein , Kiel 24105 , Germany Center of Neurology and Hertie‐Institute for Clinical Brain ResearchUniversity of TübingenTübingenGermany; Department of Medical GeneticsUniversity of TübingenTübingenGermany Center of Neurology, Department of Neurodegeneration and Hertie‐Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany; German Center for Neurodegenerative Diseases University of Tuebingen Tuebingen Germany; Department of Neurology Christian‐Albrechts University Kiel Germany From the Department of Neurodegenerative Diseases (S.B., B.R., I.L.-S.), Hertie Institute for Clinical Brain Research; German Center for Neurodegenerative Diseases (S.B., B.R., I.L.-S.), Tübingen; Department of Neurology (O.G., W.M., D.B.), Christian-Albrechts-University, Kiel, Germany; Janssen Research and Development, a Division of Janssen Pharmaceutica N.V. (M.T., L.V.N., J.S.), Beerse; Reference Center for Biological Markers of Dementia (M.T.), Institute Born-Bunge, University of Antwerp,... Department of Neurology Christian‐Albrecht‐University Kiel Kiel Germany; Department of Neurodegeneration and Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany Department of Neurology, UKSH‐Kiel Campus Christian‐Albrechts‐University Kiel Germany Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany; Department of Neurology Christian‐Albrechts‐University Kiel Kiel Germany Center of Neurology, Department of Neurodegeneration and Hertie‐Institute for Clinical Brain Research & German Center for Neurodegenerative Diseases University of Tuebingen Tuebingen Germany; Department of Neurology Christian‐Albrechts University Kiel Germany Department of Neurology, Universitätsklinikum Schleswig‐Holstein Christian‐Albrechts‐University Kiel Germany Department of Neurodegenerative Diseases Hertie‐Institute for Clinical Brain Research, University of Tübingen Tübingen Germany Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, 72076 Tuebingen, Germany; German Center of Neurodegenerative Diseases (DZNE), University of Tuebingen, 72076 Tuebingen, Germany Department of Neurology Christian Albrechts‐University Kiel Kiel Germany Department of Neurodegeneration Hertie Institute for Clinical Brain Research, University of Tuebingen Tuebingen Germany; Department of Neurology Christian‐Albrechts‐University Kiel Germany; German Center for Neurodegenerative Diseases (DZNE) Tuebingen Germany Hertie Institute of Clinical Brain Research, University of Tübingen, Tübingen, Germany. daniela.berg@uni-tuebingen.de Klinik für Neurologie, UKSH, Campus Kiel, Christian‐Albrechts‐Universität Kiel Germany Center of Neurology Department of Neurodegeneration and Hertie‐Institute for Clinical Brain Research University of Tuebingen Tuebingen Germany; Department of Neurology Christian‐Albrechts‐University of Kiel Kiel Germany |
Incoming Links
Total number of triples: 670.